Cidofovir Powder
NDC Package 48954-728-00
Package Information
Cidofovir powders is a medication used with probenecid to treat a certain viral eye infection (retinitis due to cytomegalovirus-CMV) in people with AIDS. This formulation utilizes a powder delivery system. Marketed by Fine Chemicals Corporation (pty) Ltd., this product is identified by NDC 48954-728.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 48954 - Fine Chemicals Corporation (pty) Ltd.
- 48954-728 -
- 48954-728-00 - 1 BAG in 1 DRUM / 2500 g in 1 BAG
- 48954-728 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 48954-728-00 identifies a specific commercial package of 1 bag in 1 drum / 2500 g in 1 bag of Cidofovir (UNFINISHED drug), a bulk ingredient labeled by Fine Chemicals Corporation (pty) Ltd.. This powder is formulated for use and contains cidofovir as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fine Chemicals Corporation (pty) Ltd. on December 21, 2009. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This drug is used with probenecid to treat a certain viral eye infection (retinitis due to cytomegalovirus-CMV) in people with AIDS. It lowers your risk of blindness and other vision problems. Cidofovir belongs to a class of drugs known as antivirals. It works by stopping the growth of the virus. Cidofovir is not a cure for CMV retinitis, and your disease may still worsen during and after treatment.
How is this Fine Chemicals Corporation (pty) Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 48954072800. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.